Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -27.12% is in line with its 5-year average of -29.16%, around the middle of its 5-year range (-43.71%–-8.23%).
17.67% above its 12-month average of -32.94%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-06-30): -9.30%.
RETURN ON ASSETS (ROA)
-27.12%
RETURN ON ASSETS (ROA) AVG TTM
-32.94%
RETURN ON ASSETS (ROA) AVG 3Y
-35.27%
RETURN ON ASSETS (ROA) AVG 5Y
-29.16%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+17.67%
CURRENT VS 3Y AVG
+23.11%
CURRENT VS 5Y AVG
+7.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.27%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+15.95%
vs the sector median at left
Optimi Health Corp.
Market Cap
$13.30M
Return on Assets (ROA)
-27.12%
TTM Avg
-32.94%
3Y Avg
-35.27%
5Y Avg
-29.16%
Market Cap
$13.33M
Return on Assets (ROA)
-85.85%
TTM Avg
-102.78%
3Y Avg
-95.22%
5Y Avg
-76.09%
Market Cap
$13.20M
Return on Assets (ROA)
-32.53%
TTM Avg
-31.07%
3Y Avg
-30.77%
5Y Avg
-29.89%
Market Cap
$13.11M
Return on Assets (ROA)
-143.44%
TTM Avg
-68.17%
3Y Avg
-65.00%
5Y Avg
-57.74%
Market Cap
$13.75M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$12.78M
Return on Assets (ROA)
-77.94%
TTM Avg
-178.68%
3Y Avg
-1009.31%
5Y Avg
-2782.57%
Market Cap
$13.86M
Return on Assets (ROA)
-172.58%
TTM Avg
-148.41%
3Y Avg
-106.72%
5Y Avg
-82.10%
Market Cap
$12.58M
Return on Assets (ROA)
-420.14%
TTM Avg
-127.99%
3Y Avg
-97.65%
5Y Avg
-85.48%
Market Cap
$14.05M
Return on Assets (ROA)
-15.57%
TTM Avg
-20.73%
3Y Avg
-20.84%
5Y Avg
-41.87%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.30M | -27.12% | -32.94% | -35.27% | -29.16% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -85.85% | -102.78% | -95.22% | -76.09% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -32.53% | -31.07% | -30.77% | -29.89% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -143.44% | -68.17% | -65.00% | -57.74% |
| Obsidian Therapeutics Inc. (OBX)vs › | $13.75M | N/A | N/A | N/A | N/A |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.78M | -77.94% | -178.68% | -1009.31% | -2782.57% |
| Sintx Technologies, Inc. (SINT)vs › | $13.86M | -172.58% | -148.41% | -106.72% | -82.10% |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | -420.14% | -127.99% | -97.65% | -85.48% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.05M | -15.57% | -20.73% | -20.84% | -41.87% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -49.12% | -29.80% | -67.98% | -117.36% |
ROA
-27.1%
ROE
-39.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-09-30 | -24.40% |
| 2024-09-30 | -41.48% |
| 2023-09-30 | -31.50% |
| 2022-09-30 | -43.71% |
| 2021-09-30 | -25.65% |
| 2020-09-30 | -8.23% |
